Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience

Sorafenib is a multi-targeted tyrosine kinase receptor inhibitor used to treat patients with advanced gastrointestinal stromal tumors (GISTs). The present study evaluated the efficacy and tolerability of sorafenib therapy for patients with GISTs. Between January 2001 and November 2012, 25 patients,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KEFELI, UMUT, BENEKLI, MUSTAFA, SEVINC, ALPER, YILDIZ, RAMAZAN, KAPLAN, MUHAMMED ALI, CILTAS, AYDIN, BALAKAN, OZAN, ISIKDOGAN, ABDURRAHMAN, COSKUN, UGUR, DANE, FAYSAL, HARPUTLUOGLU, HAKAN, KARACA, HALIT, YAZILITAS, DOGAN, DURNALI, AYSE, KAYA, ALI OSMAN, DEMIRCI, UMUT, GUMUS, MAHMUT, BUYUKBERBER, SULEYMAN
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2013
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3789037/
https://ncbi.nlm.nih.gov/pubmed/24137379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2013.1408
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge